Literature DB >> 7843794

Suppression by isoproterenol of endothelial cell morphology and barrier function changes induced by platelet-activating factor.

Z Ding1, S Li, M Jiang, Z Wu.   

Abstract

Using a model to study vascular permeability on hydrostatically perfused bovine pulmonary artery endothelial cell (EC) monolayers and software to analyze cell morphological parameters automatically in a computer image workstation, we studied the effects of isoproterenol (IPN) on platelet-activating factor (PAF)-induced changes in EC monolayer permeability and cell morphological parameters. Albumin has fortifying effects on endothelial barrier function. As albumin concentration in the perfusate increased (0, 1, 5, 10, 20 mg/ml), EC monolayer hydraulic conductivity (Lp) decreased gradually while Lp of the filter membranes did not change. After treatment of the EC monolayer with PAF 10(-8) mol/liter for 30 min, transmonolayer fluid flow, protein clearance rate, and Lp value increased noticeably. At the same time, cell area decreased and intercellular distance and percentage of intercellular space area in total cell monolayer increased. Pretreatment with 10(-4) mol/liter IPN blocked PAF-induced EC permeability and morphological changes, suggesting that EC contraction and intercellular gap formation are important mechanisms for PAF-induced high vascular permeability. IPN inhibits the effects of PAF via stabilization of EC morphology, protection of intercellular junction, and blockade of intercellular gap formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7843794     DOI: 10.1007/bf01560696

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  28 in total

1.  Attenuation of IL-2-induced multisystem organ edema by phalloidin and antamanide.

Authors:  R Welbourn; G Goldman; L Kobzik; C R Valeri; H B Hechtman; D Shepro
Journal:  J Appl Physiol (1985)       Date:  1991-03

Review 2.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

3.  An in vitro system for measuring endothelial permeability under hydrostatic pressure.

Authors:  M Baetscher; K Brune
Journal:  Exp Cell Res       Date:  1983-10-15       Impact factor: 3.905

4.  Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures.

Authors:  F Bussolino; G Camussi; M Aglietta; P Braquet; A Bosia; G Pescarmona; F Sanavio; N D'Urso; P C Marchisio
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

5.  Isoproterenol or aminophylline attenuate pulmonary edema after acid lung injury.

Authors:  I Mizus; W Summer; I Farrukh; J R Michael; G H Gurtner
Journal:  Am Rev Respir Dis       Date:  1985-02

6.  Inflammatory agonists that increase microvascular permeability in vivo stimulate cultured pulmonary microvessel endothelial cell contraction.

Authors:  N M Morel; P P Petruzzo; H B Hechtman; D Shepro
Journal:  Inflammation       Date:  1990-10       Impact factor: 4.092

7.  Isoproterenol and aminophylline reduce lung capillary filtration during high permeability.

Authors:  T Foy; J Marion; K L Brigham; T R Harris
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-01

8.  Norepinephrine and iloprost improve barrier function of human endothelial cell monolayers: role of cAMP.

Authors:  E G Langeler; V W van Hinsbergh
Journal:  Am J Physiol       Date:  1991-05

9.  Antiallergic mechanisms of beta-adrenergic stimulants in rats.

Authors:  N Inagaki; T Miura; H Nagai; A Koda
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

10.  Phalloidin prevents leukocyte emigration induced by proinflammatory stimuli in rat mesentery.

Authors:  H Asako; R E Wolf; D N Granger; R J Korthuis
Journal:  Am J Physiol       Date:  1992-12
View more
  1 in total

1.  Vascular barrier-enhancing effect of an endogenous beta-adrenergic agonist.

Authors:  Z Ding; M Jiang; S Li; Y Zhang
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.